» Articles » PMID: 12086629

Both Natural and Designed Micro RNAs Can Inhibit the Expression of Cognate MRNAs when Expressed in Human Cells

Overview
Journal Mol Cell
Publisher Cell Press
Specialty Cell Biology
Date 2002 Jun 28
PMID 12086629
Citations 311
Authors
Affiliations
Soon will be listed here.
Abstract

Animal cells have recently been shown to express a range of approximately 22 nucleotide noncoding RNAs termed micro RNAs (miRNAs). Here, we show that the human mir-30 miRNA can be excised from irrelevant, endogenously transcribed mRNAs encompassing the predicted 71 nucleotide mir-30 precursor. Expression of the mir-30 miRNA specifically blocked the translation in human cells of an mRNA containing artificial mir-30 target sites. Similarly, designed miRNAs were also excised from transcripts encompassing artificial miRNA precursors and could inhibit the expression of mRNAs containing a complementary target site. These data indicate that novel miRNAs can be readily produced in vivo and can be designed to specifically inactivate the expression of selected target genes in human cells.

Citing Articles

IL-1ra and CCL5, but not IL-10, are promising targets for treating SMA astrocyte-driven pathology.

Allison R, Mangione C, Suneja M, Gawrys J, Melvin B, Belous N Mol Ther. 2024; 33(2):734-751.

PMID: 39673131 PMC: 11853362. DOI: 10.1016/j.ymthe.2024.12.016.


Discovery of miRNA-mRNA regulatory networks in glioblastoma reveals novel insights into tumor microenvironment remodeling.

Grigore I, Rajagopal A, Chow J, Stone T, Salmena L Sci Rep. 2024; 14(1):27493.

PMID: 39528571 PMC: 11555236. DOI: 10.1038/s41598-024-78337-y.


Recent advances in methylation modifications of microRNA.

Su N, Yu X, Duan M, Shi N Genes Dis. 2024; 12(1):101201.

PMID: 39524539 PMC: 11550756. DOI: 10.1016/j.gendis.2023.101201.


Research Progress on miRNAs and Artificial miRNAs in Insect and Disease Resistance and Breeding in Plants.

Ma Z, Wang J, Li C Genes (Basel). 2024; 15(9).

PMID: 39336791 PMC: 11431169. DOI: 10.3390/genes15091200.


Strategies for HIV-1 suppression through key genes and cell therapy.

Sorokina A, Anchakova E, Dashinimaev E Front Med (Lausanne). 2023; 10:1259995.

PMID: 38093984 PMC: 10716291. DOI: 10.3389/fmed.2023.1259995.